Skip to main content
Caplight Logo









Continuum+

Continuum+

Private
ParisHealthcare & Life Scienceshttps://continuumplus.net

Last Round

Crowdfunding

Sep 27, 2024

Total Funding Raised

$1.06M

Company Overview

Continuum+ operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Crowdfunding round in September 2024.

Continuum+ is a healthtech company that provides a digital and human accompaniment platform for monitoring cancer patients undergoing oral anti-cancer therapy at home.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Continuum+ Comparables

Compare Continuum+ with similar companies based on industry and business-model similarity.

Continuum+ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cureety
85%
Resilience
81%
Sivan Innovation Ltd.
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Continuum+ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingSep 27, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Continuum+ Investors

Notable investors and investment history

Continuum+ investors
InvestorRounds
SowefundCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 155% MoM, from 2K to 5K.

  • Jan 2, 2026

    Monthly visitors increased 36% MoM, reaching 9.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Continuum+ Filings

Explore SEC and related filing metadata, where available.

Continuum+ filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Continuum+'s valuation, stock price, and market status.

Is Continuum+ a public or private company?

Continuum+ is a private company.

What is the current stock price of Continuum+?

Continuum+ is a private company, so its shares have no public market price. Caplight tracks Continuum+'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Continuum+ worth (valuation)?

Valuation information for Continuum+ is not publicly available.

Can I buy Continuum+ stock?

Continuum+ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Continuum+'s last funding round?

Continuum+'s most recent funding round was Crowdfunding on September 27, 2024.

Who are the main investors in Continuum+?

Key investors in Continuum+ include Sowefund.

Will Continuum+ IPO soon?

No public IPO plans have been announced for Continuum+.

How can I track Continuum+ secondary market activity?

Caplight tracks bids, offers, and trades in Continuum+'s shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range13
Year Founded2017
Last FundingSep 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?